Electra Therapeutics Inc.
ETRAHealthcare|Medical - Pharmaceuticals|US
$7.80
+0.45 (+6.12%)
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05416307 Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | P2P3 | Recruiting | 156 | Open-label | ELA026 |
| NCT07465835 A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) | T Cell Malignancies | P1 | Recruiting | 84 | Open-label | ELA026 |
| NCT05556863 Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers | Healthy Volunteers | P1 | Completed | 91 | RCT, Double-blind | ELA026, ELA026 |